# Evaluation of Thiol Disulfide Balance in Stage 1 Endometrium Cancer

> **NCT04175067** · — · COMPLETED · sponsor: **Muğla Sıtkı Koçman University** · enrollment: 117 (actual)

## Conditions studied

- Endometrium Cancer
- Oxidative Stress

## Interventions

- **DIAGNOSTIC_TEST:** Disulphide(μmol/L)
- **DIAGNOSTIC_TEST:** Total Oxidant Capacity(μmolH2O2Equiv/L)

## Key facts

- **NCT ID:** NCT04175067
- **Lead sponsor:** Muğla Sıtkı Koçman University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-01
- **Primary completion:** 2019-10-31
- **Final completion:** 2019-11-15
- **Target enrollment:** 117 (ACTUAL)
- **Last updated:** 2019-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04175067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04175067, "Evaluation of Thiol Disulfide Balance in Stage 1 Endometrium Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04175067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*